brl-28500 has been researched along with Abortion--Septic* in 1 studies
1 other study(ies) available for brl-28500 and Abortion--Septic
| Article | Year |
|---|---|
Ticarcillin/clavulanate for the treatment of female genital tract infections. Efficacy, safety and comparative microbiology.
In an open study, ticarcillin/clavulanate was used to treat upper genital tract infections in 91 women. The clinical success rate was 92% in outpatient-acquired salpingitis (pelvic inflammatory disease), 50% in salpingitis with tuboovarian abscess, 85% in postpartum endometritis, 87% in endometritis after chorioamnionitis and 90% in postoperative parametritis. The primary adverse reaction was diarrhea, in 10 patients. Among the 129 aerobes isolated, 18 (14%) were beta-lactamase positive, as were 32% (20/63) of the anaerobes. Topics: Abortion, Septic; Adult; Bacteria; beta-Lactamase Inhibitors; Cellulitis; Clavulanic Acids; Drug Evaluation; Drug Therapy, Combination; Endometritis; Female; Genital Diseases, Female; Humans; Pelvic Inflammatory Disease; Penicillins; Pregnancy; Ticarcillin | 1990 |